Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Support letter for inclusion of Daclatasvir on 4th March, 2015.
